Ador Multi Products Ltd
Incorporated in 1986, Ador Multiproducts Ltd manufactures and distributes cosmetic and personal care products[1]
- Market Cap ₹ 14.9 Cr.
- Current Price ₹ 31.9
- High / Low ₹ 45.9 / 27.6
- Stock P/E
- Book Value ₹ 23.2
- Dividend Yield 0.00 %
- ROCE -33.6 %
- ROE -26.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -1.56% over past five years.
- Promoter holding is low: 38.6%
- Company has a low return on equity of -40.6% over last 3 years.
- Working capital days have increased from 53.1 days to 78.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
5.80 | 6.69 | 6.57 | 7.28 | 9.87 | 19.34 | 13.44 | 12.17 | 6.73 | 2.87 | |
6.76 | 8.02 | 7.35 | 8.56 | 12.96 | 20.42 | 19.81 | 20.69 | 10.17 | 4.77 | |
Operating Profit | -0.96 | -1.33 | -0.78 | -1.28 | -3.09 | -1.08 | -6.37 | -8.52 | -3.44 | -1.90 |
OPM % | -16.55% | -19.88% | -11.87% | -17.58% | -31.31% | -5.58% | -47.40% | -70.01% | -51.11% | -66.20% |
0.14 | 2.27 | 0.16 | 0.18 | 0.54 | 4.27 | 0.30 | 0.31 | 0.96 | 5.07 | |
Interest | 0.32 | 0.34 | 0.20 | 0.07 | 0.38 | 0.29 | 0.31 | 0.15 | 0.30 | 0.23 |
Depreciation | 0.18 | 0.09 | 0.12 | 0.20 | 0.26 | 0.36 | 0.43 | 0.69 | 0.53 | 0.55 |
Profit before tax | -1.32 | 0.51 | -0.94 | -1.37 | -3.19 | 2.54 | -6.81 | -9.05 | -3.31 | 2.39 |
Tax % | -34.09% | 45.10% | 3.19% | -0.73% | -10.66% | 40.94% | 1.91% | 0.66% | 21.45% | |
-0.88 | 0.28 | -0.97 | -1.36 | -2.85 | 1.50 | -6.93 | -9.11 | -4.02 | 1.66 | |
EPS in Rs | -3.07 | 0.98 | -3.39 | -3.62 | -7.19 | 3.21 | -14.83 | -19.49 | -8.60 | 3.55 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -2% |
3 Years: | -30% |
TTM: | -72% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 79% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | -8% |
3 Years: | -27% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -36% |
3 Years: | -41% |
Last Year: | -27% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 2.86 | 2.86 | 2.86 | 3.76 | 3.96 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 |
Reserves | -0.49 | 2.54 | 0.94 | 1.74 | 3.87 | 8.79 | 16.07 | 10.55 | 6.36 | 6.18 |
2.32 | 2.57 | 0.50 | 0.59 | 4.23 | 2.58 | 0.61 | 0.06 | 0.00 | 0.00 | |
1.48 | 2.01 | 1.93 | 2.65 | 4.84 | 2.89 | 2.46 | 3.63 | -2.91 | -3.74 | |
Total Liabilities | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 18.91 | 8.12 | 7.11 |
1.15 | 5.34 | 1.29 | 2.20 | 6.77 | 7.69 | 8.74 | 8.17 | 3.33 | 2.99 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.26 | 1.37 | 1.40 | 3.00 | 0.13 | 0.86 | 0.61 | 0.62 | 0.61 | 0.61 |
4.76 | 3.27 | 3.54 | 3.54 | 10.00 | 10.38 | 14.46 | 10.12 | 4.18 | 3.51 | |
Total Assets | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 18.91 | 8.12 | 7.11 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
0.00 | 9.43 | -3.52 | -0.56 | -3.68 | -7.06 | -8.62 | -6.76 | -0.54 | |
0.00 | -3.17 | 3.63 | -2.89 | 3.18 | 4.19 | -0.90 | 0.19 | 1.65 | |
0.00 | 0.03 | 0.05 | 3.45 | 1.09 | 2.69 | 12.91 | 0.36 | -0.03 | |
Net Cash Flow | 0.00 | 6.29 | 0.16 | -0.01 | 0.59 | -0.18 | 3.40 | -6.20 | 1.08 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 67.97 | 64.38 | 87.22 | 65.68 | 91.71 | 35.48 | 43.72 | 39.59 | 10.30 |
Inventory Days | 107.30 | 102.89 | 68.10 | 82.64 | 197.54 | 136.34 | 204.03 | 201.72 | 93.23 |
Days Payable | 89.71 | 82.47 | 66.57 | 95.04 | 184.51 | 86.86 | 179.32 | 239.78 | 71.63 |
Cash Conversion Cycle | 85.56 | 84.79 | 88.75 | 53.28 | 104.75 | 84.95 | 68.43 | 1.53 | 31.90 |
Working Capital Days | 67.97 | -79.66 | 59.44 | 17.05 | -80.62 | 18.87 | 90.16 | -9.60 | 78.64 |
ROCE % | -19.75% | -12.55% | -25.02% | -34.54% | -9.54% | -41.27% | -66.42% | -33.55% |
Documents
Announcements
- Financial Results For The Period Ended 30Th September, 2024 17 Oct
-
Board Meeting Outcome for Approval Of Un-Audited Financial Statements For The Period Ended 30Th September, 2024
17 Oct - Approved un-audited financial statements for Q2 2024.
-
Board Meeting Intimation for Meeting To Be Held On 17Th October, 2024 To Discuss And Approve Un-Audited Results For The Quarter And Half Year Ended 30Th September, 2024
14 Oct - Board meeting to discuss financial results on 17th October.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct
- Closure of Trading Window 30 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is a contract manufacturer of personal care products in India, offering one-stop shop from product conception to finished goods and undertaking private labelling